Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 2
1983 1
2008 1
2012 1
2013 1
2014 4
2015 3
2016 9
2017 2
2018 2
2019 6
2020 6
2021 7
2022 2
2023 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial.
Yahav D, Franceschini E, Koppel F, Turjeman A, Babich T, Bitterman R, Neuberger A, Ghanem-Zoubi N, Santoro A, Eliakim-Raz N, Pertzov B, Steinmetz T, Stern A, Dickstein Y, Maroun E, Zayyad H, Bishara J, Alon D, Edel Y, Goldberg E, Venturelli C, Mussini C, Leibovici L, Paul M; Bacteremia Duration Study Group. Yahav D, et al. Among authors: dickstein y. Clin Infect Dis. 2019 Sep 13;69(7):1091-1098. doi: 10.1093/cid/ciy1054. Clin Infect Dis. 2019. PMID: 30535100 Clinical Trial.
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.
Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD, Skiada A, Andini R, Eliakim-Raz N, Nutman A, Zusman O, Antoniadou A, Pafundi PC, Adler A, Dickstein Y, Pavleas I, Zampino R, Daitch V, Bitterman R, Zayyad H, Koppel F, Levi I, Babich T, Friberg LE, Mouton JW, Theuretzbacher U, Leibovici L. Paul M, et al. Among authors: dickstein y. Lancet Infect Dis. 2018 Apr;18(4):391-400. doi: 10.1016/S1473-3099(18)30099-9. Epub 2018 Feb 16. Lancet Infect Dis. 2018. PMID: 29456043 Clinical Trial.
Microbiota manipulation for weight change.
Dror T, Dickstein Y, Dubourg G, Paul M. Dror T, et al. Among authors: dickstein y. Microb Pathog. 2017 May;106:146-161. doi: 10.1016/j.micpath.2016.01.002. Epub 2016 Jan 12. Microb Pathog. 2017. PMID: 26792677
Trends in antimicrobial resistance in Israel, 2014-2017.
Dickstein Y, Temkin E, Ish Shalom M, Schwartz D, Carmeli Y, Schwaber MJ. Dickstein Y, et al. Antimicrob Resist Infect Control. 2019 Jun 4;8:96. doi: 10.1186/s13756-019-0535-1. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 31171967 Free PMC article.
Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.
Paul M, Dickstein Y, Borok S, Vidal L, Leibovici L. Paul M, et al. Among authors: dickstein y. Cochrane Database Syst Rev. 2014 Jan 14;(1):CD003914. doi: 10.1002/14651858.CD003914.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2017 Jun 03;6:CD003914. doi: 10.1002/14651858.CD003914.pub4. PMID: 24425445 Updated. Review.
46 results